EVerZom
FranceEntry
2025
Hold
1yr
Status
Active
Who owns EVerZom?
EVerZom is a French Biotech company, currently owned by Audacia since 2025 and 3 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Aloe Private EquitySorbonne Venture · 2022 · VC
4 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Key takeaways
- ·Co-held by Erganeo, Audacia, Capital Grand Est and Aloe Private Equity since 2019.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2019 · present
ErganeoActive
2019 · present(7yr) · Erganeo · 2012 · VC
Aloe Private EquityActive
2025 · present(1yr) · Sorbonne Venture · 2022 · VC
Capital Grand EstActive
2025 · present(1yr) · Cap Innov'Est 2 · 2021 · VC
AudaciaActive
2025 · present(1yr) · Sorbonne Venture by Audacia · 2020 · VC
More from Sorbonne Venture
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns EVerZom?
EVerZom is currently owned by Audacia, Capital Grand Est and 2 others, through Sorbonne Venture, since 2025.
When did Audacia and 3 others acquire EVerZom?
Audacia and 3 others acquired EVerZom in 2025.
Who has owned EVerZom over time?
EVerZom has been through 4 private-equity ownership periods: Erganeo · via Erganeo · since 2019; Audacia · via Sorbonne Venture by Audacia · since 2025; Capital Grand Est · via Cap Innov'Est 2 · since 2025; Aloe Private Equity · via Sorbonne Venture · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue